Nature Aging Study Links HSC Immune Memory to Inflammaging, Raising New Targets for Age-Related Disease
Updated
Updated · BIOENGINEER.ORG · Aug 10
Nature Aging Study Links HSC Immune Memory to Inflammaging, Raising New Targets for Age-Related Disease
2 articles · Updated · BIOENGINEER.ORG · Aug 10
Summary
A Nature Aging study proposes that maladaptive trained immunity in hematopoietic stem cells may be a central driver of inflammaging—the chronic, low-grade inflammation tied to cardiovascular, neurodegenerative, metabolic and frailty-related disorders.
Repeated inflammatory signals appear to leave durable marks on bone-marrow stem cells through chromatin, DNA methylation, metabolic and transcription-factor changes, causing them to keep producing inflammation-prone immune cells long after the original threat fades.
That model helps explain why aging blood production often shifts toward myeloid cells and away from some lymphoid output, leaving older immune systems both more inflammatory and less adaptable.
The paper also connects this mechanism to clonal hematopoiesis, where altered stem-cell clones can expand and release cytokines such as interleukin-1 beta and interleukin-6, sustaining body-wide inflammation without ongoing infection.
Potential therapies would target bone marrow and stem-cell regulatory networks rather than broadly suppress inflammation, though researchers say future work must determine which trained-immunity signals are reversible without weakening infection defense or vaccine responses.